Medical Automation Market
Market Insights on Medical Automation covering sales outlook, demand forecast & up-to-date key trends
Medical Automation Market by Application, End-Use, & Region – Forecast 2022–2032
Medical automation market Snapshot
The global medical automation market size is expected to surpass an impressive valuation of USD 44.45 billion in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.6% from 2023 to 2033.
A few of the leading drivers for the medical automation market are the adoption of automated instruments by drug discovery departments of pharmaceutical companies, the rise in need for miniaturization, and technological advancements coupled with the rise in demand for robot-assisted surgeries.
Additional contributing factors include increased government initiatives, an increase in clinical trials due to greater R&D outsourcing to emerging nations, and rising expenditures for infrastructure developmnt. For instance, due to government initiatives that prioritize domestic innovation in nations like South Korea and China, more domestic manufacturers in the surgical automation industry specialize in robotic-assisted surgeries. Examples include Curexo in South Korea, which even serves as the local distributor for THINK Surgical's Solution robotic system, and TINAVI Medical Technologies in China. Over the forecast period, an increase in local companies will be key to the market's growth.
Due to shutdown restrictions and disruptions in logistics management, the COVID-19 pandemic severely impacted the medical device market. However, due to the wide range of application usage, the medical automation market experienced little to no impact and saw a noticeable increase in demand. This is in support of the micro markets covered in the report, for instance, the market for laboratory and pharmacy automation, the market for medical software, informatics, and logistics, and, to a smaller extent, the market for therapeutic automation, which all showed evidence of benefit from the COVID-19 pandemic. For instance, even if the COVID-19 pandemic had a detrimental effect on robotic system sales, most players ended 2020 with strong demand for their products. For instance, over 100 robotic systems were put in by Stryker and Zimmer Biomet in the fourth quarter of 2020 for their MAKO and ROSA systems, respectively. This indicates that the rising demand for robotic surgeries is likely to be strong beyond 2020.
Anticipated Base Year Value (2022) |
US$ 44.45 Billion |
Expected Market Value (2023) |
US$ 48.07 Billion |
Projected Forecast Value (2033) |
US$ Billion 102.4 billion |
Global Growth Rate (2023-2033) |
10.6% CAGR |
Growth Rate of the U.S Market (2023-2033) |
8.5% CAGR |
Expected Market share of Asia Pacific (2032) |
US$ 900 million (Approx.) |
Europe Market Expansion Rate (2022-2032) |
7.95%CAGR |
Key Companies Profiled |
|
Let us know your requirement to get
100% FREE customization
2018-2022 Medical automation market Demand Analysis vs. Forecast 2023-2033
Over the past few years, there has been an increase in the demand for medical automation systems markets. This is due to the rising adoption of healthcare automation by the research organization & labs has contributed to the growth of the market in terms of value sales and it is also anticipated to offer lucrative opportunities for the growth of the healthcare automation market during the forecast period.
The growing need for medical automation is driven by the rising investments in R&D activities by companies. Companies and medical institutions are transferring more funds into medical automation systems and software enticed by benefits such as cost reduction, increased speed, greater transparency in processing, and reduction in errors. This, therefore, lays a robust foundation for the growth of the global medical automation market. Another change that is propelling the adoption of medical automation is the high degree of interest in point-of-care testing devices for pregnancy, blood glucose levels, blood pressure, and HIV.
Considering these factors, The global medical automation market size is anticipated to surpass an impressive valuation of USD 44.45 billion in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.6% during the forecast period.
Which are Some key Drivers of the Medical automation market?
Rising application of medical automation in research centers to propel market growth
In recent years, healthcare automation has provided advanced solutions to pharmacy hospital automation, material handling, logistics & transport, and other applications. Research institutes & labs all across the world are increasingly investing in the development of healthcare automation to perform several related activities as well as to improve the overall efficiency of the work. Additionally, healthcare automation plays a significant role in research organizations to reinforce the overall productivity in providing medical facilities, enhancing quality, and others.
In addition to this, the increasing adoption of healthcare automation by the research organization & labs has contributed to the growth of the market in terms of value sales and it is also expected to offer lucrative opportunities for the growth of the healthcare automation market during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich factors are restraining the growth of the medical automation market?
Insufficient government investment in economically developing nations hampers the market growth
Insufficient government investment in developing countries including Sri Lanka, Africa, Pakistan, and others is restraining the growth of the healthcare automation market in these economies. Therefore, healthcare automation manufacturers can work side by side with the government to improve investment in the advancement of technology. Thereby, it helps in bolstering the reliability of both healthcare automation providers as well as the government. Additionally, the ongoing “Digital India” Movement initiated by the Indian government has a significant role in improving the medical infrastructure as well as medical services network in the country.
What are the key challenges for the medical automation market?
Scarcity of experts and high costs of installation hamper the market growth
The high cost of installation, as well as maintenance costs of healthcare automation and the security & privacy issues, are some of the major factors that are hampering the growth of the overall healthcare automation market in terms of value sales globally. Furthermore, the weak configurability of healthcare automation is the factor that is likely to restrain the global spread of healthcare automation systems during the forecast year. Additionally, the lack of highly skilled professionals is likely to hinder the growth & implementation of innovative technology.

A unified Market Research Subscription Platform, built for today's disparate research needs.
Region-Wise Analysis
High R&D investments accelerating the medical automation market of North America
North America dominated the industry in 2022 due to high R&D investments, product launches, and government initiatives. Furthermore, the growth is attributed to the presence of a well-established healthcare infrastructure, which has increased the use of laboratory automation in the region. In addition, the supportive reimbursement framework and the regional presence of major players in this region are also augmenting the penetration of novel solutions in the market.
Consumers with high cases of chronic diseases such as diabetes, cardiovascular disease, cancer, and others are also fuelling the requirement for government assistance in healthcare automation technology. Additionally, the rising demand for robotic surgery and good medical services as well as increasing preference for diagnostics & monitoring automation is augmenting the market growth in the U.S.
Developed medical infrastructure to augment the market growth of Europe
The Europe medical automation market is expected to expand at a CAGR of 9.30% from 2023 to 2033. The growing demand for technology-driven systems, the presence of major players, and the presence of well-established and developed healthcare infrastructure are expected to contribute to the region's market growth.
In addition, the presence of government agencies, such as the Medicines and Healthcare Products Regulatory Agency, is critical in certifying pharmacy automation systems and other devices with European standards, which is anticipated to give growth opportunities in the coming years for this regional market.
Asia-Pacific exhibits the fastest growth rate among all regions
Asia-Pacific is expected to be the fastest-growing segment during the forecast period. This is attributable to the growth of medical infrastructure, rising consumer awareness, and increasing application of automated technology in the medical sector in countries like China, India, and others. Moreover, the healthcare automation industry is also growing owing to the rise in the geriatric population along with rising cases of chronic disease, the proliferation of medical infrastructure, and others.
Category-Wise Analysis
Therapeutic automation in the medical field is dominating the segment with 53.5% of total market revenue
The market is supported by the expansion of the surgical automation segment, which is growing at a compound annual growth rate of over 9%. This is a combination of both technical developments and an increase in the strategic initiatives taken by the companies. For instance, organizations' strategic initiatives, such as the BPCI, CJR, and advanced value-based reimbursement models, have given manufacturers the chance to offer supplementary goods and services that will successfully broaden the continuum of care.
The market is supported by the growth of the intraoperative imaging segment, which made up more than 64% of the overall imaging automation market in 2022
Hospitals and Diagnostics lead the segment with the highest market share
The end-use segment is dominated by hospitals and diagnostic centers with over 51.0% share in 2022. The dominance is due to the increasing automation in medical laboratory science and the rising usage of automated equipment in diagnostics, treatment, and laboratories. The rise of this industry is being driven by automation in pharmacies and hospitals, particularly in tier 2 and tier 3 cities of the growing economies of Asia Pacific, including India. For example, institutions like Apollo and Fortis in India are working to offer computerized healthcare services that are functioning in tier 2 and tier 3 towns.
The research laboratories & institutes segment is anticipated to grow at a positive compound annual growth rate of over 9%. This is attributed to the presence of government-assisted agencies and acceptance of the new products launched into the market.
Start-ups in the medical automation market
Several companies have revolutionized the medical automation systems market by launching various startups. These startups are expanding the market and creating numerous growth prospects for the industry. Some recently launched startups are-
- MindMaze- MindMaze is a switcherland-based company that was launched in 2016. It received an investment of USD 125 million. It is one of the top healthcare startups and is known as the global leader in digital neurotherapeutics. It's a platform for neurorehabilitation and recovery of brain function after injury, stroke, and similar illnesses. MindMaze is a collection of virtual reality products managed by healthcare specialists that helps patients recover brain function and adapt to more or less normal life. It’s most widely used in rehabilitation patients after traumatic brain injury and stroke, with Alzheimer's and Parkinson's, and in those suffering from various phobias.
- Onera Health- is a Netherlands-based company. Onera is an at-home medical-grade sleep diagnostic patch system that helps monitor sleeping and the body's condition during the night. It's accurate, comfortable, wireless, intuitive, and as simple to use as possible. It singles it out among other digital health startups to watch related to sleeping problems. The system's main benefit is replacing some intimidating examinations and lab tests with its functions. This year alone, it raised €10.4 million in Series B funding, was recognized with Frost & Sullivan Award, won two Red Dot Awards 2021, and received a € 2.4 million EIC grant to transform sleep medicine post-pandemic remote monitoring.
Market Competition
- In Jan 2022, medical technology industry Becton, Dickinson, and Company declared acquisition with Parata systems for more than $1.5 billion. Parata systems offer automation products for pharmacies like inventory management software, the high-speed robotic process for medical automation, robotic dispensers, workflow solutions, and adherence packaging tools. The Becton, Dickinson company’s acquisition purpose is to operate pharmacies for people’s healthier lives.
- In 2021, Siemens Healthineers AG acquired Varian Medical Systems, Inc. This is a German medical device company that allows the earlier to increase access to the latter's comprehensive portfolio as well as strengthen its position in the MedTech sector.
- In 2021, Philips acquisition with Capsule Technologies, Inc. They are providers of medical device integration and data technologies for hospitals and healthcare organizations. The purpose is to enlarge Philips’s leadership in patient care management solutions. Capsule Technologies, Inc is providing medical device Information platforms such as device integration, clinical surveillance services, and vital signs monitoring. Philips’s strategy is to transform the delivery of healthcare in the health field with integrated solutions. It helps to connect almost all medical devices as well as EMRs in hospitals.
- In 2021, IBM acquired mylnvenio to expand its automation portfolio with the latest acquisition. MyInvenio, is an Italy-founded process mining technology vendor. IBM provides IT and business process automation services to other organizations through automation groups such as Intelligent Document Processing, RPA, process orchestration capabilities, and Intelligent Virtual Agents. myInvenio acquired clients globally across the North American, UK regions, APAC, European, and others across key sectors like healthcare, pharmaceutical, banking, and financial services. This company helps with data-driven process discovery, and monitoring to identify process improvement, analysis, and transformation opportunities.
Key players in the medical automation market are
- Accuray, Inc.
- Tecan Group Ltd.
- Medtronic Plc.
- Swisslog Holding AG
- GE Healthcare
- Intuitive Surgical, Inc.
- Stryker Corporation
- Siemens AG
- Koninklijke Philips N.V.
- Danaher Corporation
- Zimmer Biomet
Key Segments Profiled in the Medical automation market Survey
By Application:
- Imaging
- therapeutic
- laboratory and pharmacy
- medical software
- Informatics
- logistics
By end use:
- Hospital and diagnostic center
- Research laboratories & institutes
- Pharmacies
- Others
By Region:
- North America
- Europe
- Asia-pacific
- Latin America
- MEA
Frequently Asked Questions
The global medical automation market is estimated at a market value of US$ 48.07 Billion.
The global medical automation market is expected to garner a market value of US$ 102.4 billion
FMI has projected North America to be one of the most lucrative regions for the medical automation market.
Therapeutic automation is going to dominate the segment with a revenue share of 53.5%.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
5.3.1. Imaging Automation Market
5.3.1.1. Integrated Image Analysis software systems
5.3.1.2. Medical Intraoperative Imaging
5.3.2. Therapeutic Automation Market
5.3.2.1. Non-Surgical Automation Market
5.3.2.2. Surgical Automation Market
5.3.3. Laboratory and Pharmacy Automation Market
5.3.3.1. Laboratory Automation Market
5.3.3.2. Pharmacy Automation Market
5.3.4. Medical Software, Informatics, and Logistics Automation Market
5.3.4.1. Software and Informatics
5.3.4.2. Logistics Automation
5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
5.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End-Use, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-Use, 2022-2032
6.3.1. Hospitals & Diagnostic Centers
6.3.2. Research Laboratories & Institutes
6.3.3. Pharmacies
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End-Use, 2017-2021
6.5. Absolute $ Opportunity Analysis By End-Use, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Application
8.2.3. By End-Use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.3.3. By End-Use
8.4. Key Takeaways
9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Application
9.2.3. By End-Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By End-Use
9.4. Key Takeaways
10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Application
10.2.3. By End-Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By End-Use
10.4. Key Takeaways
11. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Application
11.2.3. By End-Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By End-Use
11.4. Key Takeaways
12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Application
12.2.3. By End-Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By End-Use
12.4. Key Takeaways
13. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Application
13.2.3. By End-Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By End-Use
13.4. Key Takeaways
14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Application
14.2.3. By End-Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By End-Use
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Application
15.1.2.2. By End-Use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Application
15.2.2.2. By End-Use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Application
15.3.2.2. By End-Use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Application
15.4.2.2. By End-Use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Application
15.5.2.2. By End-Use
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Application
15.6.2.2. By End-Use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Application
15.7.2.2. By End-Use
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Application
15.8.2.2. By End-Use
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Application
15.9.2.2. By End-Use
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Application
15.10.2.2. By End-Use
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Application
15.11.2.2. By End-Use
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Application
15.12.2.2. By End-Use
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Application
15.13.2.2. By End-Use
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Application
15.14.2.2. By End-Use
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Application
15.15.2.2. By End-Use
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Application
15.16.2.2. By End-Use
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Application
15.17.2.2. By End-Use
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Application
15.18.2.2. By End-Use
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Application
15.19.2.2. By End-Use
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Application
15.20.2.2. By End-Use
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Application
15.21.2.2. By End-Use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Application
16.3.3. By End-Use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Accuray, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Tecan Group Ltd.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Medtronic Plc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Swisslog Holding AG
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. GE Healthcare
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Intuitive Surgical, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Stryker Corporation
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Siemens AG
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Koninklijke Philips N.V.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Danaher Corporation
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Zimmer Biomet
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 3: Global Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 4: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 6: North America Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 9: Latin America Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 12: Europe Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 13: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: South Asia Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 15: South Asia Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 16: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: East Asia Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 18: East Asia Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 19: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Oceania Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 21: Oceania Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Table 22: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 23: MEA Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 24: MEA Market Value (US$ Mn) Forecast by End-Use, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Application, 2022-2032
Figure 2: Global Market Value (US$ Mn) by End-Use, 2022-2032
Figure 3: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 10: Global Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 11: Global Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 13: Global Market Attractiveness by Application, 2022-2032
Figure 14: Global Market Attractiveness by End-Use, 2022-2032
Figure 15: Global Market Attractiveness by Region, 2022-2032
Figure 16: North America Market Value (US$ Mn) by Application, 2022-2032
Figure 17: North America Market Value (US$ Mn) by End-Use, 2022-2032
Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 28: North America Market Attractiveness by Application, 2022-2032
Figure 29: North America Market Attractiveness by End-Use, 2022-2032
Figure 30: North America Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Market Value (US$ Mn) by Application, 2022-2032
Figure 32: Latin America Market Value (US$ Mn) by End-Use, 2022-2032
Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 40: Latin America Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 43: Latin America Market Attractiveness by Application, 2022-2032
Figure 44: Latin America Market Attractiveness by End-Use, 2022-2032
Figure 45: Latin America Market Attractiveness by Country, 2022-2032
Figure 46: Europe Market Value (US$ Mn) by Application, 2022-2032
Figure 47: Europe Market Value (US$ Mn) by End-Use, 2022-2032
Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 55: Europe Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 58: Europe Market Attractiveness by Application, 2022-2032
Figure 59: Europe Market Attractiveness by End-Use, 2022-2032
Figure 60: Europe Market Attractiveness by Country, 2022-2032
Figure 61: South Asia Market Value (US$ Mn) by Application, 2022-2032
Figure 62: South Asia Market Value (US$ Mn) by End-Use, 2022-2032
Figure 63: South Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 64: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: South Asia Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 68: South Asia Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 70: South Asia Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 71: South Asia Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 72: South Asia Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 73: South Asia Market Attractiveness by Application, 2022-2032
Figure 74: South Asia Market Attractiveness by End-Use, 2022-2032
Figure 75: South Asia Market Attractiveness by Country, 2022-2032
Figure 76: East Asia Market Value (US$ Mn) by Application, 2022-2032
Figure 77: East Asia Market Value (US$ Mn) by End-Use, 2022-2032
Figure 78: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 79: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: East Asia Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 83: East Asia Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 85: East Asia Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 86: East Asia Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 88: East Asia Market Attractiveness by Application, 2022-2032
Figure 89: East Asia Market Attractiveness by End-Use, 2022-2032
Figure 90: East Asia Market Attractiveness by Country, 2022-2032
Figure 91: Oceania Market Value (US$ Mn) by Application, 2022-2032
Figure 92: Oceania Market Value (US$ Mn) by End-Use, 2022-2032
Figure 93: Oceania Market Value (US$ Mn) by Country, 2022-2032
Figure 94: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 97: Oceania Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 100: Oceania Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 101: Oceania Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 103: Oceania Market Attractiveness by Application, 2022-2032
Figure 104: Oceania Market Attractiveness by End-Use, 2022-2032
Figure 105: Oceania Market Attractiveness by Country, 2022-2032
Figure 106: MEA Market Value (US$ Mn) by Application, 2022-2032
Figure 107: MEA Market Value (US$ Mn) by End-Use, 2022-2032
Figure 108: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 109: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 112: MEA Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 113: MEA Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 115: MEA Market Value (US$ Mn) Analysis by End-Use, 2017-2032
Figure 116: MEA Market Value Share (%) and BPS Analysis by End-Use, 2022-2032
Figure 117: MEA Market Y-o-Y Growth (%) Projections by End-Use, 2022-2032
Figure 118: MEA Market Attractiveness by Application, 2022-2032
Figure 119: MEA Market Attractiveness by End-Use, 2022-2032
Figure 120: MEA Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports